Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

Gastrin Level

Immunology & Autoimmune

Fasting GastrinSerum GastrinS-Gastrin

Review status

Currently under review

Pending specialist review and validation.

What it shows

A Gastrin Level test measures the amount of the hormone gastrin in your blood. Gastrin is made by cells in the lower stomach and upper small intestine. It signals your stomach to produce acid for digestion and helps maintain the health of the stomach lining.

This test is typically performed on a fasting blood sample because eating naturally raises gastrin. It is used along with your symptoms, medication history, and sometimes additional stomach acid assessments to evaluate how well your body regulates acid production.

Why it matters

Abnormal gastrin levels can indicate problems with acid regulation in the stomach. Markedly increased levels may occur with gastrin-producing tumors, long-term acid suppression, chronic inflammation of the stomach lining, or low acid states. Low or inappropriately normal levels in someone with symptoms may point to other causes of acid-related problems.

Clinicians order this test for recurrent or hard-to-treat ulcers, unexplained chronic diarrhea, abdominal pain, vitamin B12 deficiency due to certain types of anemia, or after stomach surgery. Results can guide decisions about imaging, endoscopy, testing for specific infections, vitamin levels, and safe adjustments to acid-suppressing medicines.

Understanding your results

Your clinician will interpret your result in the context of whether you were fasting, which medications you take, your stomach acid status, kidney function, and other tests. Higher-than-expected results are common with proton pump inhibitors or H2 blockers, with low stomach acid states, Helicobacter pylori infection, chronic atrophic gastritis, pernicious anemia, kidney problems, or a gastrin-producing tumor. A normal result does not exclude disease if you were not fasting or are taking acid-suppressing drugs.

If your result is elevated, your care team may repeat the test under standardized conditions, adjust medications, or order follow-up studies such as gastric pH measurement, a secretin stimulation test, endoscopy, imaging, or vitamin B12 testing. If results are normal or low but symptoms persist, they may look for other explanations. Do not stop or change any medicines without discussing it with your clinician.

Reference ranges

053 pmol/L
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact Gastrin Level

  • Fasting and recent meals

    Eating, especially protein-rich meals, naturally raises gastrin. A true fasting sample is preferred to avoid a misleadingly high result.

  • Acid-suppressing medicines

    Proton pump inhibitors and H2 blockers can increase gastrin by lowering stomach acid. Your clinician may advise a safe hold before testing.

  • Gastric acidity and infections

    Low stomach acid and Helicobacter pylori infection can stimulate gastrin release. Treating the underlying condition may normalize levels.

  • Kidney function

    Reduced kidney function can decrease clearance of gastrin, leading to higher measured levels even without increased production.

  • Prior stomach surgery or anatomy

    Procedures such as gastric bypass or vagotomy, and chronic atrophic gastritis, can alter acid feedback and raise gastrin.

  • Biologic variability and timing

    Gastrin can fluctuate during the day. Consistent timing and standardized conditions help make results easier to compare.

2026

References

  1. McGill University Health Centre. (2017, March 01). Gastrin Level (Task CD 316490). Laboratory reference ranges.
  2. Falconi, M., Eriksson, B., Kaltsas, G., Bartsch, D. K., Capdevila, J., Klöppel, G., ... O’Toole, D. (2016). ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors. Neuroendocrinology, 103(2), 153–171.
  3. National Comprehensive Cancer Network. (2024). Neuroendocrine and adrenal tumors (NCCN Clinical Practice Guidelines in Oncology).